TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. NORWICH PHARMACEUTICALS, INC. et al, No. 2:2020cv08966 - Document 419 (D.N.J. 2022)
Court Description: OPINION AND ORDER denying without prejudice 401 Plaintiff's Motion in Limine. Signed by Judge Stanley R. Chesler on 10/24/2022. (qa, )
Download PDF
<![CDATA[
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. NORWICH PHARMACEUTICALS, INC. et al Doc. 419 Case 2:20-cv-08966-SRC-CLW Document 419 Filed 10/24/22 Page 1 of 2 PageID: 69692 UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY TAKEDA PHARMACEUTICAL COMPANY LIMITED et al., Plaintiffs, v. NORWICH PHARMACEUTICALS, INC. et al., Defendants. : : : : : : : : : : : : Civil Action No. 20-8966 (SRC) OPINION & ORDER CHESLER, District Judge This matter comes before the Court on the motion in limine by Plaintiffs Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals U.S.A. Inc. (collectively, “Takeda”) seeking to preclude Defendant Norwich Pharmaceuticals, Inc. (“Norwich”) from offering argument or evidence at trial regarding its strategy in this litigation. For the reasons that follow, the motion will be denied without prejudice. As Norwich argues in opposition, Takeda has not explained how the material it seeks to exclude is relevant to the issues to be tried, patent infringement and invalidity. Because of this, the motion will be denied, but without prejudice: should the issue arise at trial, Takeda is free to renew the motion. For these reasons, IT IS on this 24th day of October, 2022 Dockets.Justia.com Case 2:20-cv-08966-SRC-CLW Document 419 Filed 10/24/22 Page 2 of 2 PageID: 69693 ORDERED that Plaintiff’s motion in limine # 1 (Docket Entry No. 401) is DENIED without prejudice. s/ Stanley R. Chesler STANLEY R. CHESLER United States District Judge 2
]]>
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You
should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
